Fresenius Medical Care AG

Fresenius Medical Care announces BEACON-US, generating real-world evidence supporting high-volume hemodiafiltration for U.S. dialysis patients

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with kidney diseases, today announced BEACON-US (Benefits, Effectiveness, And Convective Outcomes in Nephrology – United States), a comprehensive scientific research initiative that is expanding clinical and real-world evidence for U.S. patients receiving online-hemodiafiltration (HDF) therapy. The initiative supports FME's ongoing roll out of high-volume HDF (HVHDF) across the United States and w

Yahoo Finance · 29/07/2026 · lire l'article ↗

Why Quest Diagnostics Stock Climbed This Past Week

Demand for medical testing services is rising.

Yahoo Finance · 27/07/2026 · lire l'article ↗

Quest Diagnostics Q2 Earnings Call Highlights

Quest Diagnostics (NYSE:DGX) reported double-digit revenue growth and raised its full-year 2026 outlook after what executives described as strong demand across its physician, hospital and consumer channels, as well as increased volume from major collaborations with Corewell Health and Fresenius Medi

Yahoo Finance · 23/07/2026 · lire l'article ↗

Hikma and Fresenius best positioned from Trump's generic drug tariffs, says Citi

Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) and Fresenius Medical Care (NYSE:FMS) could emerge as relative winners from Donald Trump's proposed tariffs on generic drugs because of their extensive US manufacturing operations, according to Citi. The US president this week announced plans to...

Yahoo Finance · 23/07/2026 · lire l'article ↗

Fresenius Medical Care introduces TherapyWise™ analytics for kidney replacement therapy

Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the introduction of TherapyWise™, a cloud-based analytics capability available within NxView™ 4.0, the Company's FDA 510(k)-cleared software platform for use with the NxStage® System One™ in the United States. TherapyWise is designed to provide retrospective, program-level insight into kidney replacement therapy (KRT) delivered in acute and hospital critical care set

Yahoo Finance · 20/07/2026 · lire l'article ↗

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

- Dr. Robert J. Kossmann has served as a prominent advocate for kidney disease patients in multiple roles including Executive Vice President and Chief Medical Officer for Fresenius Medical Care North America - - Dr. Prabir Roy-Chaudhury is the Immediate Past President of the American Society of Nephrology, serves as the Drs Ronald and Katherine Falk Eminent Professor at UNC, and is the Co-Director of the UNC Kidney Center - DURHAM, N.C., July 14, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq:

Yahoo Finance · 14/07/2026 · lire l'article ↗